Q, W., F, J., Y, X., Y, L., L, Z., & X, S. (2025). Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus. Clinical pharmacokinetics, 64(12), 1785. https://doi.org/10.1007/s40262-025-01570-9
Chicago Style (17th ed.) CitationQ, Wang, Jiang F, Xu Y, Lei Y, Zhang L, and Sun X. "Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus." Clinical Pharmacokinetics 64, no. 12 (2025): 1785. https://doi.org/10.1007/s40262-025-01570-9.
MLA (9th ed.) CitationQ, Wang, et al. "Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus." Clinical Pharmacokinetics, vol. 64, no. 12, 2025, p. 1785, https://doi.org/10.1007/s40262-025-01570-9.
Warning: These citations may not always be 100% accurate.